Announcement on Obtaining FDA Approval by Subsidiary for Propofol Injectable Emulsion
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Obtaining FDA Approval by Subsidiary for Propofol Injectable Emulsion
Filed with SSE · · 2 pages · Chinese
On 6ix: 6ix.com/news/announcement-on-obtaining-fda-approval-by-subsidiary-for-propofol-injectable-emulsion
Release
Nanjing King-friend Biochemical Pharmaceutical Co., Ltd. on 6ix
Earlier from Nanjing King-friend Biochemical Pharmaceutical
- Announcement on Approval of Subsidiary's Product Dalbavancin for Injection by the U.S. FDA
- Announcement on Election of Employee Representative Directors for the 5th Board of Directors
- Announcement on Subsidiary's Acquisition of U.S. FDA Approval for Additional Production Site of Vecuronium Bromide for Injection
- Announcement on Voluntary Disclosure of Nadroparin Calcium Injection Passing Consistency Evaluation of Quality and Efficacy of Generic Drugs
- Announcement on Subsidiary Obtaining FDA New Drug Approval for Fosfomycin for Injection
Later from Nanjing King-friend Biochemical Pharmaceutical
- Indicative Announcement on the Expected Fulfillment of Conversion Price Amendment Conditions for ""King-Friend Convertible Bonds"
- Announcement on Not Revising Downward Conversion Price of ""King-friend Convertible Bonds"
- Indicative Announcement on the Proposed Reversal of Inventory Impairment
- Announcement on Completing Industrial and Commercial Change Registration
- Announcement on Obtaining FDA Approval by Subsidiary for Sodium Selenite Injection
Follow Nanjing King-friend Biochemical Pharmaceutical into a list and get an email when it puts out news.
Follow Nanjing King-friend Biochemical Pharmaceutical